Table 1 Patient and treatment characteristics (n = 22)
Characteristics | Number of patients (%) |
|---|---|
Age | |
 ≧60 y.o. | 17(77.3) |
 <60 y.o. | 5(22.7) |
Gender | |
 Male | 18(81.8) |
 Female | 4(18.2) |
ECOG | |
 0 | 3(13.6) |
 1 | 17(77.3) |
 2 | 2(9.1) |
BCLC | |
 B | 2(9.1) |
 C | 20(90.9) |
Vascular extension (PVTT & IVCTT) | |
 Yes | 16(72.7) |
 No | 6(27.3) |
Child-Pugh stage | |
 A | 20(90.9) |
 B | 2(9.1) |
Hepatitis virus | |
 B | 12(54.5) |
 C | 4(18.2) |
Non B non C | 6(27.3) |
AFP | |
 <1500 | 15(68.2) |
 1500 | 7(31.8) |
Tumor Location | |
 Right | 21(95.5) |
 Left | 1(4.5) |
Tumor type | |
 Solitary | 11(50) |
 Multiple | 8(36.4) |
 Diffuse | 3(13.6) |
Tumor size | |
 10 cm | 7(31.8) |
 >10 cm | 15(68.2) |
Radiation dose | |
 40 Gy | 16(72.7) |
 < 40 Gy | 6(27.3) |
Pre-SBRT treatment | |
 Yes | 9(40.9) |
 No | 13(59.1) |
Post – SBRT treatment | |
 Yes | 6(27.3) |
 No | 16(72.7) |